Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with L
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q4 2022 | LACTOSE MONOHYDRATE | VAGINAL | TABLET, FILM COATED | 17.90 mg | Deletion | ||
| Q3 2022 | LACTOSE MONOHYDRATE | VAGINAL | INSERT | 210.00 mg | MDE Replacement | ||
| Q4 2022 | LACTOSE MONOHYDRATE | VAGINAL | INSERT | 630mg | MDE Replacement | ||
| Q3 2022 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | ORAL | TABLET, FILM COATED | 40.00 mg | MDE Replacement | ||
| Q4 2022 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | ORAL | TABLET, FILM COATED | 40mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: October 1, 2022
Database Last Updated: October 19, 2022